Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EGFR inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof

EGFR inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof

US Patent 10561646 · Granted Feb 18, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Occupant protection method and system, and computer readable medium2025
Polymorph of CDK9 inhibitor and preparation method for polymorph and use thereof2025
Alpha-herpesvirus insensitive monoclonal cell strain, and preparation method the2025
Adenosine triphosphatase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 2025
Substituted heterocyclic fused cyclic compound, preparation method therefor and 2024
Method for extracting Gymnadenia conopsea and related Gymnadenia conopsea extrac2024
Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative a2021
4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivative2021
4,5,6-trisubstituted indazole derivatives, and preparation method and pharmaceut2021
FGFR4 inhibitor and preparation method and use thereof2021
Sodium ion channel inhibitors and pharmaceutically acceptable salts and polymorp2021
N-sulfonyl benzamides as voltage-gated sodium channel inhibitors2020